Besuchen Sie uns an unserem Stand 242.

Besuchen Sie uns an unserem
STAND Nr. 13

Unser Symposium zu Angiotensin II bei septischem Schock
07.09.2026 | 12:00 – 13:30 Uhr | Raum NORDSEE

We look forward to meeting you at our booth: 106!
Join us at our symposium in the Stiftersaal (Ebene 02), June 06, 2026: 15:30 – 16:30 Uhr

We look forward to meeting you at our booth: 106 !
Join us at our symposium in the Stiftersaal (Ebene 02), June 06,.2026: 15:30 – 16:30 Uhr

Meet us at our booth 31+46
and join us for our two symposia in Room Ríma A on June 11:
13:00–14:30 – Remimazolam, 15:00–16:30 – Angiotensin II

We look forward to meeting you at our booth: 31+46!

We look forward to meeting you at our booth 32!

Come visit us at our
BOOTH No. 2.10

Our Symposium: Advances in the ICU: Sedation, Shock and Severe Infections
October 13, 2026 | 12:30 – 1:30 p.m. | Room: Auditorium 1

PAION Pharma

Your reliable partner for intensive care and anesthesiology

We are a pharmaceutical company specializing in the research, development, manufacture and distribution of medicinal products. Our goal is to make a significant contribution to improving patient care. Since February 2024, we have been operating independently as a subsidiary of the Humanwell Healthcare Group under the name PAION Pharma GmbH.

To the
News

PAION Pharma GmbH is an independent company with a focus on innovative products in intensive care medicine and anesthesiology. As part of the Humanwell Healthcare Group, we utilize strong synergies in this area and are thus further expanding our position as a sustainable and reliable partner in the healthcare sector. Tilmann Bur, Managing Director

Our Clusters for Strategic Growth

Growth

Development of a continuous growth strategy for our existing and future products across Europe, as well as exploring additional licensing and distribution opportunities.

Distribution

Strengthening and expanding existing and new professional distribution strategies for our anesthetic and intensive care pharmaceuticals

Patents

Global patent portfolio and evaluation of synergy, in-licensing, and out-licensing opportunities

Partner

Reliable partner for the supply of pharmaceutical compounds

Patents

Global patent portfolio and evaluation of synergy, in-licensing, and out-licensing opportunities

Partner

Reliable partner for the supply of pharmaceutical compounds

Management

Executive Management

Tilmann Bur
Managing Director

Proven track record in the pharmaceutical industry
Executive with international management experience,
Key Competency: Extensive experience in professional relationship management with decision-makers in hospitals, as well as in building and leading national and international sales organizations and dealer networks.